当前位置：
X-MOL 学术
›
Aliment. Pharm. Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Editorial: Cardiometabolic criteria matters in MASLD—Authors' reply
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2024-09-03 , DOI: 10.1111/apt.18243 Nobuharu Tamaki 1 , Takefumi Kimura 2 , Shun-Ichi Wakabayashi 2 , Takeji Umemura 2 , Namiki Izumi 1 , Rohit Loomba 3 , Masayuki Kurosaki 1
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2024-09-03 , DOI: 10.1111/apt.18243 Nobuharu Tamaki 1 , Takefumi Kimura 2 , Shun-Ichi Wakabayashi 2 , Takeji Umemura 2 , Namiki Izumi 1 , Rohit Loomba 3 , Masayuki Kurosaki 1
Affiliation
This article is linked to Tamaki et al papers. To view these articles, visit https://doi.org/10.1111/apt.18205 and https://doi.org/10.1111/apt.18233
中文翻译：
社论：心脏代谢标准在 MASLD 中很重要——作者的回复
本文链接到 Tamaki 等人的论文。要查看这些文章，请访问 https://doi.org/10.1111/apt.18205 和 https://doi.org/10.1111/apt.18233
更新日期：2024-09-03
中文翻译：
社论：心脏代谢标准在 MASLD 中很重要——作者的回复
本文链接到 Tamaki 等人的论文。要查看这些文章，请访问 https://doi.org/10.1111/apt.18205 和 https://doi.org/10.1111/apt.18233
京公网安备 11010802027423号